Valuation : Medpace Holdings, Inc.

Market Cap 16.58B 14.28B 13.41B 12.24B 22.97B 1,578B 23.13B 159B 61.74B 800B 62.23B 60.89B 2,649B P/E 2026 *
33.8x
P/E 2027 * 31x
Enterprise Value 15.78B 13.58B 12.76B 11.65B 21.86B 1,501B 22.02B 151B 58.75B 761B 59.22B 57.94B 2,521B EV / Sales 2026 *
5.53x
EV / Sales 2027 * 5.06x
Free-Float
80.32%
Yield 2026 *
-
Yield 2027 * -
1 day-1.11%
1 week-4.20%
Current month+2.92%
1 month+2.92%
3 months+31.57%
6 months+27.64%
Current year+5.76%
1 week 583.16
Extreme 583.1575
625.44
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
26/08/26 Exercice

Director

11,574 0.0415%
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
24/08/26 Sell

Chief Executive Officer

-1,983 0.0071%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%-4.20%+25.49%+119.78% 16.77B
-1.23%-1.91%+0.98%+17.94% 50.47B
-1.11%-2.84%+420.04%+505.15% 44.56B
-0.21%+0.53%+36.88%+16.32% 43.08B
-1.95%-3.33%+8.29%+73.25% 41.7B
-0.94%-1.77%+18.34%+46.84% 33.21B
+6.10%+4.40% - - 16.28B
+0.25%-0.41%+11.91%+29.03% 14.58B
-1.12%-2.35%+76.50%+37.47% 13.92B
-2.96%-4.89%-7.23%-36.53% 13.12B
Average -0.43%-1.24%+65.69%+89.92% 28.77B
Weighted average by Cap. -0.71%-1.06%+84.30%+114.96%

Financials

2026 *2027 *
Net sales 2.85B 2.46B 2.31B 2.11B 3.95B 271B 3.98B 27.32B 10.62B 138B 10.7B 10.47B 456B 3.03B 2.61B 2.45B 2.23B 4.19B 288B 4.22B 29B 11.27B 146B 11.36B 11.12B 484B
Net income 503M 433M 406M 371M 696M 47.82B 701M 4.81B 1.87B 24.26B 1.89B 1.85B 80.31B 547M 471M 442M 404M 757M 52.01B 763M 5.24B 2.04B 26.38B 2.05B 2.01B 87.35B
Net Debt -802M -691M -649M -592M -1.11B -76.34B -1.12B -7.69B -2.99B -38.72B -3.01B -2.95B -128B -1.25B -1.08B -1.01B -925M -1.74B -119B -1.75B -12B -4.66B -60.44B -4.7B -4.6B -200B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
31/08/26 $593.99 -1.11% 346,442
28/08/26 $600.65 -1.79% 186,917
27/08/26 $611.57 -1.21% 198,155
26/08/26 $619.05 +0.81% 149,419
25/08/26 $614.06 -0.96% 247,113
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
593.99USD
Average target price
581.83USD
Spread / Average Target
-2.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock